Tim cấy ghép là một điều trị được thành lập vì suy tim tiên tiến. Kinh nghiệm lâm sàng và tiến bộ trong việc ức chế miễn dịch đã tăng lên sự sống còn người nhận đến hơn 80% 1 năm, 10 năm tồn tại là hơn 50% ở nhiều biến chứng thông thường sau khi cấy ghép tim (HTX) bao gồm từ chối cấp tính, nhiễm trùng, allograft tim | 234 Chapter 18 Mader MT Poulton TB White RD. Malignant tumors of the heart and great vessels MR imaging appearance. Radiographics 1997 17 145. Meng Q Lai H Lima J et al. Echocardiographic and pathologic characteristics of primary cardiac tumors a study of 149 cases. Int J Cardiol 2002 84 69. Schvartzman PR White RD. Imaging of cardiac and paracardiac masses. J Thorac Imaging 2000 15 265. Siripornpitak S Higgins CB. MRI of primary malignant cardiovascular tumors. J Comput Assist Tomogr 1997 21 462. CHAPTER 19 Evaluation of the transplanted heart Oberdan Parodi Maria Frigerio and Benedetta De Chiara Introduction Cardiac transplantation is an established treatment for advanced heart failure. Clinical experience and progress in immunosuppression have increased recipient survival to more than 80 at 1 year 10-year survival is more than 50 at many Common complications after heart transplantation HTx include acute rejection infections cardiac allograft vasculopathy CAV and lymphoproliferative disorders and other malignancies as well as other conditions mainly related to side-effects of immunosuppressive drugs Fig. . This chapter summarizes briefly the role of cardiac imaging techniques for the diagnosis of acute rejection and will provide a more in-depth review of current techniques for invasive and non-invasive evaluation of CAV. Case Presentation A 55-year-old man with idiopathic dilated cardiomyopathy underwent heart transplantation in 1999 from a donor of the same age and gender. The patient had cytomegalovirus infection and one treated acute rejection episode in the early postoperative months. One year after heart transplantation the resting ECG showed an incomplete right bundle branch block and further evaluation was sought for surveillance for rejection and allograft vasculopathy. Diagnosis of acute cardiac allograft rejection Acute rejection is an important cause of death in HTx recipients accounting for 20 of the deaths occurring in the first .
